後藤 美賀子

Systematic review of the treatment of rheumatoid arthritis patients of reproductive age: Informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis - secondary publication. 

Modern rheumatology 2025年10月8日  

Limitations of FAERS-based analyses of paternal drug exposure: The critical need for maternal data integration. 

Andrology 2025年10月3日  

Maternal Mosapride Citrate Hydrate Exposure During the First Trimester: Assessing Risks for Congenital Anomalies. 

Digestive diseases and sciences 2025年7月9日  

Five-Year Delivery Rate and Time to Delivery Among Women With and Without Rheumatoid Arthritis: A Real-World Analysis Using a Nationwide Claims Database in Japan. 

International journal of rheumatic diseases 28(6) e70296 2025年6月  

Evaluation of Data Quality and Utility of the Japan Drug Information Institute in Pregnancy (JDIIP) Consultation Case Database for Pregnancy Pharmacovigilance 

Drug Safety 2025年5月15日  

Pharmacovigilance Pregnancy Data in a Population of Japanese Patients With Chronic Inflammatory Disease Exposed to Certolizumab Pegol. 

International journal of rheumatic diseases 28(1) e70048 2025年1月  

Transfer of amenamevir into breast milk in breastfeeding patients with recurrent herpes simplex: study protocol for a single-arm, open-label study. 

Frontiers in pediatrics 13 1551335-1551335 2025年  

A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan 

Congenital Anomalies 65(1) 2024年12月  

Effects of famotidine use during pregnancy: an observational cohort study. 

Journal of pharmaceutical health care and sciences 10(1) 70-70 2024年11月8日  

Pregnancy outcomes after first‐trimester exposure to fluoroquinolones: <scp>Findings</scp> based on an integrated database from two <scp>Japanese</scp> institutions 

Congenital Anomalies 2024年6月27日  

Risk of major birth defects after first-trimester exposure to carbocisteine and ambroxol: A multicenter prospective cohort study using counseling data for drug safety during pregnancy. 

Congenital anomalies 64(3) 91-98 2024年5月  

Pregnancy-related issues from the perspective of patients with inflammatory rheumatic diseases – Results from a survey of the members of the National Association for Inflammatory Rheumatic Diseases 

Modern Rheumatology 2024年3月5日  

妊娠と薬情報センターの授乳相談例からみた周産期メンタルヘルスの課題 

日本小児科学会雑誌 128(2) 358-358 2024年2月  

Assessment of the Safety of Exposure to Cefcapene Pivoxil during the First Trimester of Pregnancy: A Prospective Cohort Study in Japan. 

Biological & pharmaceutical bulletin 47(7) 1301-1306 2024年  

妊娠初期におけるクラリスロマイシン服用の胎児への影響についての評価 

日本周産期・新生児医学会雑誌 59(Suppl.1) P298-P298 2023年6月  

Long-term physical and neurodevelopmental outcomes after antenatal betamethasone administration for congenital heart block prevention. 

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 35(21) 4175-4178 2022年11月  

Pregnancy Outcomes With Exposure to Second-Generation Antipsychotics During the First Trimester. 

The Journal of clinical psychiatry 83(4) 2022年6月8日  

Analysis of triptan use during pregnancy in Japan: A case series. 

Congenital anomalies 62(2) 78-81 2022年3月  

Tocilizumab drug levels during pregnancy and lactation: A woman who discontinued tocilizumab therapy until the end of the first trimester and resumed it after birth. 

Obstetric medicine 14(4) 260-262 2021年12月